EU Commission Senior Balkan Deputy Valdis Dombrovskis made statements about the mechanism that subjects the coronavirus vaccine exports at a press conference in Brussels.
Stating that they made changes in the regulation of the export authorization mechanism, Dombrovskis said that they brought the principles of “reciprocity and proportionality” to vaccine exports. He explained that if a country with significant production capacity restricts the export of vaccines or substances used in production, exports to this country will go through the evaluation process.
THE RIGHT BALANCE MUST BE ACHIEVED
Pointing out that the right balance should be achieved in vaccine exports, Dombrovskis emphasized that epidemiological situation and vaccination rates will be taken into consideration when sending vaccines to a country.
EXCLUDED COUNTRIES WITHIN THE SCOPE OF THE REGULATION
Dombrovskis stated that with the new regulation, some countries that were exempted from the vaccine authorization mechanism were included in the scope of the regulation, thus preventing circumvention of the rules.
Claiming that the EU has used the vaccine authorization mechanism in a balanced way, Dombrovskis explained that only 1 of the 381 requests belonging to AstraZeneca, which did not fulfill its commitments to the EU, were not accepted.
Dombrovskis said the EU has approved a total of 43 million doses of vaccine sent to 33 countries since the end of January. In the statement of the EU Commission on the subject, since the start of the mechanism, 10 million 900 thousand from the EU to England, 6 million 600 thousand to Canada, 5 million 400 thousand to Japan, 4 million 400 thousand to Mexico, It was recorded that 1 million 500 thousand doses of vaccine were sent to Singapore and Chile, 1 million 300 thousand to Hong Kong and 1 million doses to Australia.
With the mechanism, it is aimed to ensure that EU citizens have timely access to Kovid-19 vaccines. Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Georgia, Israel, Jordan, Iceland, Lebanon, Libya, Liechtenstein, Montenegro, Norway, North Macedonia, Serbia and Switzerland, which were previously outside the scope of the mechanism, have also been included in the system.
ABOUT THE MECHANISM
Vaccines produced in the facilities of BioNTech-Pfizer, AstraZeneca, Sanofi-GSK, Johnson and Johnson, CureVac and Moderna, with which the EU signed a pre-purchase agreement with the mechanism that limits the export of Kovid-19 vaccine, cannot be sold to other countries without permission.
The sale of the vaccine outside the EU is possible if the country of manufacture and the EU Commission allow. In order to obtain permission, companies must deliver the amount of vaccine they have promised to provide to the EU.
The EU’s new restriction is expected to affect Britain, first of all. The fact that AstraZeneca firm gave the UK priority in procurement and could not fulfill its commitments to EU countries caused annoyance.